Stonebridge Capital Advisors
PLXP

Stonebridge Capital Advisors’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Stonebridge Capital Advisors’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,250
Closed -$95K – 163
2016
Q1 		$95K Buy
+1,250
New +$79.5K 0.03% 144

Other funds holding PLXP

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Tourbillon Capital Partners
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Lone Star Value Management
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lombard Odier Asset Management (USA)
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
Great Point Partners
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Emerald Acquisition
Emerald Acquisition Seattle, Washington $51.8B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Timpani Capital Management
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

Stonebridge Capital Advisors's PLXP Position: Q2 2016 in Review

Stonebridge Capital Advisors sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2016, closing a stake of 1,250 shares — an estimated $95K sold.

Stonebridge Capital Advisors first reported a position in PLXP in Q1 2016 and held it in 1 quarter. The position peaked at $95K in Q1 2016. 33 funds tracked by Wall St. Rank hold PLXP as of Q2 2016.

  • Stonebridge Capital Advisors reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 1,250 PLx Pharma Inc. Common Stock shares in Q2 2016, an estimated $95K.
  • Stonebridge Capital Advisors first reported a position in PLx Pharma Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Stonebridge Capital Advisors's PLx Pharma Inc. Common Stock position peaked at $95K in Q1 2016.
  • 33 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2016.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2016, filed 16 Aug 2016.